Alex Sinclair is the most eminent CSO of any ASX pharma below 500 million market cap. She is the key KOL in the IHH space and has clinical experience. I cannot think of another CSO in any pre revenue pharma who runs the biggest clinic in the world in their specialist disease area.
I think that Tom Duthey is excellent and the IR of the company is clear, concise and considered and as good or better than any microcap pharma on the ASX.
Alex Sinclair is the most eminent CSO of any ASX pharma below...
Add to My Watchlist
What is My Watchlist?
